GALECTIN THERAPEUTICS INC Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Galectin Therapeutics Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Galectin Therapeutics Inc Return On Equity for the quarter ending September 30, 2024 was 57.6 %, a 36.5% decline year-over-year.
  • Galectin Therapeutics Inc annual Return On Equity for 2023 was 77.6 %, a 58.6% decline from 2022.
  • Galectin Therapeutics Inc annual Return On Equity for 2022 was 187 %.
  • Galectin Therapeutics Inc annual Return On Equity for 2021 was -303 %, a 315% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 77.6 -110 -58.6% Jan 1, 2023 Dec 31, 2023
2022 187 +490 Jan 1, 2022 Dec 31, 2022
2021 -303 -230 -315% Jan 1, 2021 Dec 31, 2021
2020 -73 -36.7 -101% Jan 1, 2020 Dec 31, 2020
2019 -36.3 +224 +86% Jan 1, 2019 Dec 31, 2019
2018 -260 +263 +50.3% Jan 1, 2018 Dec 31, 2018
2017 -523 -311 -147% Jan 1, 2017 Dec 31, 2017
2016 -211 -98 -86.3% Jan 1, 2016 Dec 31, 2016
2015 -113 -49.3 -76.8% Jan 1, 2015 Dec 31, 2015
2014 -64.2 -3.66K -102% Jan 1, 2014 Dec 31, 2014
2013 3.6K +3.84K Jan 1, 2013 Dec 31, 2013
2012 -243 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.